Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted ...
Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, the next ...
11d
The event will be webcast live and may be accessed via a link in the Investors section of the Nurix website. The archived webcast will be available for 30 days after the event. About Nurix ...
SG Americas Securities LLC lifted its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX – Free Report) by 31.1% in the fourth quarter, according to the company in its most recent ...
The strong performance of NX-5948 has bolstered confidence in Nurix's protein degradation platform. Analysts note that the early Progression-Free Survival (PFS) curves for BTK degraders appear ...
The strong performance of NX-5948 has bolstered confidence in Nurix's protein degradation platform. Analysts note that the early Progression-Free Survival (PFS) curves for BTK degraders appear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback